BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

831 related articles for article (PubMed ID: 19471257)

  • 1. Idiopathic portal hypertension in patients with HIV infection treated with highly active antiretroviral therapy.
    Chang PE; Miquel R; Blanco JL; Laguno M; Bruguera M; Abraldes JG; Bosch J; Garcia-Pagan JC
    Am J Gastroenterol; 2009 Jul; 104(7):1707-14. PubMed ID: 19471257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fundal variceal bleeding after correction of portal hypertension in patients with cirrhosis.
    Rinella ME; Shah D; Vogelzang RL; Blei AT; Flamm SL
    Gastrointest Endosc; 2003 Jul; 58(1):122-7. PubMed ID: 12838239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea].
    Kim MY; Baik SK; Suk KT; Yea CJ; Lee IY; Kim JW; Cha SH; Kim YJ; Um SH; Han KH
    Korean J Hepatol; 2008 Jun; 14(2):150-8. PubMed ID: 18617762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and laboratory predictors of esophageal varices in children and adolescents with portal hypertension syndrome.
    Fagundes ED; Ferreira AR; Roquete ML; Penna FJ; Goulart EM; Figueiredo Filho PP; Bittencourt PF; Carvalho SD; Albuquerque W
    J Pediatr Gastroenterol Nutr; 2008 Feb; 46(2):178-83. PubMed ID: 18223377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic portal hypertension in a systemic sclerosis patient heterozygous for factor V Leiden mutation.
    Ishii M; Katada Y
    Rheumatol Int; 2003 Jan; 23(1):44-6. PubMed ID: 12548441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Underlying mechanism of portal hypertensive gastropathy in cirrhosis: a hemodynamic and morphological approach.
    Curvêlo LA; Brabosa W; Rhor R; Lanzoni V; Parise ER; Ferrari AP; Kondo M
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1541-6. PubMed ID: 19743998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoscopic treatment of esophagogastric variceal bleeding in patients with noncirrhotic extrahepatic portal vein thrombosis: a long-term follow-up study.
    Spaander MC; Darwish Murad S; van Buuren HR; Hansen BE; Kuipers EJ; Janssen HL
    Gastrointest Endosc; 2008 May; 67(6):821-7. PubMed ID: 18206153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis.
    Turnes J; Garcia-Pagan JC; Abraldes JG; Hernandez-Guerra M; Dell'Era A; Bosch J
    Am J Gastroenterol; 2006 Mar; 101(3):506-12. PubMed ID: 16542287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergent treatment of variceal bleeding in two infants.
    Park A; Cwikiel W
    Acta Radiol; 2008 Oct; 49(8):951-4. PubMed ID: 18720085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Portal hypertension-related complications after acute portal vein thrombosis: impact of early anticoagulation.
    Turnes J; García-Pagán JC; González M; Aracil C; Calleja JL; Ripoll C; Abraldes JG; Bañares R; Villanueva C; Albillos A; Ayuso JR; Gilabert R; Bosch J
    Clin Gastroenterol Hepatol; 2008 Dec; 6(12):1412-7. PubMed ID: 19081529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The predictive value of serum laminin for the risk of variceal bleeding related to portal pressure levels.
    Kondo M; Miszputen SJ; Leite-mor MM; Parise ER
    Hepatogastroenterology; 1995; 42(5):542-5. PubMed ID: 8751212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Idiopathic portal hypertension].
    Orozco H; Takahashi T; García-Tsao G; Mercado MA; Diliz H; Hernández-Ortiz J
    Rev Invest Clin; 1991; 43(1):80-6. PubMed ID: 1866503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic portal hypertension and its pathology.
    Okudaira M; Ohbu M; Okuda K
    Semin Liver Dis; 2002 Feb; 22(1):59-72. PubMed ID: 11928079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic hemodynamics in 24 patients with nodular regenerative hyperplasia and symptomatic portal hypertension.
    Bissonnette J; Généreux A; Côté J; Nguyen B; Perreault P; Bouchard L; Pomier-Layrargues G
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1336-40. PubMed ID: 22554152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV.
    Schiano TD; Kotler DP; Ferran E; Fiel MI
    Am J Gastroenterol; 2007 Nov; 102(11):2536-40. PubMed ID: 17640321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive model predicting clinically-significant portal hypertension in patients with advanced fibrosis.
    Park SH; Park TE; Kim YM; Kim SJ; Baik GH; Kim JB; Kim DJ
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1289-93. PubMed ID: 19682196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controversies and certitudes on the upper digestive hemorrhage through rupture of esophageal varices. I. Pathophysiology of portal hypertension and mechanism of rupture of the esophageal varices.
    Voiculescu M
    Med Interne; 1988; 26(3):179-90. PubMed ID: 3055241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel developments in esophageal vascular disorders.
    de Franchis R; Dell'Era A
    Curr Opin Gastroenterol; 2008 Jul; 24(4):490-5. PubMed ID: 18622165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non-cirrhotic portal hypertension: rare cause of upper gastrointestinal bleeding].
    Schouten JN; Verheij J; Janssen HL
    Ned Tijdschr Geneeskd; 2010; 154():A1276. PubMed ID: 20456763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.